Health, Innovation, Transformers, Pharmaceutical, Drugs.
unsafe or ineffective, so they don’t reach the market. Creating drugs for rare diseases is also a risky and costly investment, so some pharmaceutical companies just avoid it altogether. Cyclica, a Toronto-based startup, is working to change the game, revolutionizing the drug development process